MRI of the Prostate: What It Shows and What Happens Next
If your GP has referred you for a prostate MRI, or your urologist has recommended one after an elevated PSA, you are probably wondering what the scan actually shows — and more importantly, what it means if something is found.
This article explains what a prostate MRI involves, how results are reported, and how the findings guide the next steps. The goal is to make the process less opaque before you go in.
Why a prostate MRI is done
A prostate MRI is typically requested when there is a clinical reason to look more closely at the prostate — most commonly a raised PSA level, a PSA that is rising over time, a high PSA density (PSA relative to prostate volume), or an abnormality felt on rectal examination.
It is not a cancer diagnosis. It is a risk stratification tool — a way of identifying which men are more likely to have clinically significant prostate cancer and therefore warrant a biopsy, and which men are less likely to and may be able to avoid one, at least for now.
This distinction matters because not every elevated PSA is caused by cancer. Benign prostate enlargement, inflammation, and infection can all raise PSA. The MRI helps determine which men are more likely to benefit from biopsy, and which may be able to avoid one — at least for now.
What the scan involves
A prostate MRI is a multi-parametric MRI — commonly abbreviated as mpMRI. It uses magnetic resonance imaging without ionising radiation to produce detailed images of the prostate and surrounding structures.
The scan typically takes 30 to 45 minutes. In most cases, a small endorectal coil is not required with modern MRI equipment, though practice varies between centres. A mild bowel preparation may be recommended beforehand to reduce artefact. An injection of contrast dye (gadolinium) is usually given during the scan to assess how blood flows through any areas of interest.
You will lie still in the scanner while the images are taken. It is not painful, though some men find it uncomfortable if they are claustrophobic. Letting the radiology centre know in advance allows them to make adjustments if needed.
How results are reported — the PI-RADS score
Prostate MRI results are reported using a standardised scoring system called PI-RADS — Prostate Imaging Reporting and Data System. The radiologist assigns a score from 1 to 5 to any area of interest in the prostate.
PI-RADS 1 — very low likelihood of clinically significant cancer. No suspicious lesion identified.
PI-RADS 2 — low likelihood. Findings are unlikely to represent clinically significant cancer.
PI-RADS 3 — intermediate or equivocal. The likelihood of clinically significant cancer is uncertain. Clinical context matters here — PSA level, PSA density, age, and other factors influence what happens next.
PI-RADS 4 — high likelihood of clinically significant cancer. Biopsy is generally recommended.
PI-RADS 5 — very high likelihood of clinically significant cancer. Biopsy is strongly recommended.
A score of 1 or 2 does not mean cancer is definitively absent — it means the MRI has not identified a suspicious lesion. Ongoing PSA surveillance is usually still appropriate. A score of 4 or 5 means a targeted biopsy is the recommended next step.
A PI-RADS 3 result is the one that most commonly generates uncertainty. In that setting, the decision about whether to proceed to biopsy depends on the broader clinical picture — not the MRI result alone.
What happens if a lesion is found
If the MRI identifies a suspicious lesion — a PI-RADS 3, 4, or 5 result — the standard next step is a targeted biopsy. Rather than taking random samples from across the prostate as older biopsy techniques did, a targeted biopsy uses the MRI images to guide sampling directly to the area of concern.
The most common approach in Australian practice is cognitive fusion biopsy — the urologist reviews the MRI images beforehand, mentally registers the location of the suspicious lesion, and then targets that area under real-time ultrasound guidance during the biopsy. This does not require specialist software or an MRI scanner in the room, and is the standard method used in most urology practices.
In some centres, software-assisted MRI-TRUS fusion biopsy — where MRI images are digitally overlaid onto real-time ultrasound — or in-bore MRI-guided biopsy are also available. These are used in selected cases but are not the routine approach for most patients.
In most cases, targeted biopsy is combined with a number of systematic cores to ensure sampling of the whole prostate as well as the identified lesion.
For more on what a biopsy involves — including how to prepare and what to expect — see Prostate Biopsy.
What happens if nothing suspicious is found
A PI-RADS 1 or 2 result is reassuring, but it does not mean further follow-up is unnecessary. If your PSA remains elevated or continues to rise, ongoing surveillance — including repeat PSA testing and possibly repeat MRI at a defined interval — is usually recommended.
The decision about how closely to monitor, and when to reconsider biopsy, is based on the trajectory of PSA over time, PSA density (PSA relative to prostate volume), age, family history, and clinical findings — an individualised assessment for each patient.
A note on how these results are interpreted
A prostate MRI result does not exist in isolation. A PI-RADS 4 finding in a 55-year-old with a rapidly rising PSA is a different clinical situation from the same finding in a 75-year-old with stable PSA and significant other health conditions. The imaging informs the decision — it does not make it.
This is the work of the consultation: taking the MRI result, the PSA history, the clinical examination findings, and the patient's own priorities and circumstances, and working out what the next step should be for that person specifically.
If you have received a prostate MRI result and are unsure what it means or what to do next, contact the rooms to arrange a consultation. For a broader overview of how prostate cancer is diagnosed and managed, see Prostate Cancer.
For information on what a prostate biopsy involves, see Prostate Biopsy.
Clinical note: This article provides general information and is not a substitute for individual medical advice. If you have received a prostate MRI result, discuss the findings and next steps with your GP or urologist.
Last reviewed: April 2026
About the author: Dr Deanne Soares is a Melbourne urologist specialising in robotic prostate, kidney and bladder cancer surgery.
